This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Sinopec Shanghai Petrochemical Announces Strategic Corporate Amendments

Tipranks - Thu Oct 23, 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Sinopec Shanghai Petrochemical Co ( (HK:0338) ) has provided an announcement.

Sinopec Shanghai Petrochemical Company Limited has announced a series of strategic amendments to its corporate structure and governance in response to recent regulatory changes in China. These amendments include the reduction of registered capital, the abolishment of the supervisory committee, and adjustments to the company’s business scope. The changes aim to align with the revised Company Law and enhance corporate governance, potentially impacting the company’s operational efficiency and market positioning. The proposed amendments will be considered at the company’s 2025 second extraordinary general meeting, with final adjustments subject to regulatory approval.

The most recent analyst rating on (HK:0338) stock is a Hold with a HK$1.13 price target. To see the full list of analyst forecasts on Sinopec Shanghai Petrochemical Co stock, see the HK:0338 Stock Forecast page.

More about Sinopec Shanghai Petrochemical Co

Sinopec Shanghai Petrochemical Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates in the petrochemical industry, focusing on the production and sale of petroleum products, petrochemical products, and synthetic fibers. The company is listed on the Hong Kong Stock Exchange and plays a significant role in the Chinese petrochemical market.

Average Trading Volume: 15,650,156

Technical Sentiment Signal: Buy

Current Market Cap: HK$26.19B

For a thorough assessment of 0338 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.